Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Schizophr Res. 2016 Dec 29;188:42–49. doi: 10.1016/j.schres.2016.12.023

Table 2.

Demographic characteristics and psychiatric medications in the Tel Aviv and the Philadelphia cohorts.

Tel Aviv Philadelphia

22q11.2DS (n = 52) WS (n =21) TD (n = 32) Statistics (df=2, 102) 22q11.2DS (n = 119) IDD (n = 129) TD (n = 800) Statistics (df=2, 1047)
Age in years 20.97 (6.49) 21.50 (6.12) 20.05 (6.52) F=0.361
p=0.70
16.51 (2.71) 15.83 (2.43) 16.29 (2.70) F=2.276
P=0.10
Age Range 12.00–36.00 11.10 – 36.01 11.00 – 34.00 12.08 – 22.0 12.00 – 21.42 12.00– 21.83
Sex (n, % male) 26 (50.0) 8 (38.0) 12 (47.0) χ2=0.85
P= 0.65
75 (63.0) 78 (60.5) 483 (60.4) χ2=0.31
p=0.86
Full scale IQ 77.98 (11.4) 65.95 (11.3) 103.23 (7.6) F=91.01
p<0.001
77.04 (12.83) NA NA
IQ Range 58–100 40–88 88–120 47 – 106 NA NA
Average parental education in years 13.43 (2.3) 14.05 (2.05) 14.72 (2.2) χ2=1.37
p=0.51
14.57 (2.04) 14.11 (2.12) 14.81 (2.36) IDD > TD
χ2=8.31
P = 0.16
Ethnicity (n, %)
 Caucasian 52 (100.0) 21 (100.0) 32 (100.0) 103 (85.1) 80 (63.0) 528 (66.8)
 African American 0 (0.0) 0 (0.0) 0 (0.0) 12 (9.9) 34 (26.8) 195 (24.7)
 Other 0 (0.0) 0 (0.0) 0 (0.0) 6 (5.0) 13 (10.2) 67 (8.5)
Medication (current)*
 Antipsychotics 1 (1.9) 0 (0.0) 0 (0.0) 2 (1.7) 7 (5.4) 2 (0.25)
 Mood stabilizers 0 (0.0) 1 (4.8) 0 (0.0) 5 (4.2) 16 (12.4) 1 (0.13)
 Anti- depressants 11 (21.2) 2 (9.5) 0 (0.0) 12 (10.1) 18 (14.0) 12 (1.5)
 Stimulants 9 (17.3) 2 (9.5) 0 (0.0) 7 (5.9) 19 (14.7) 18 (2.3)
 Anxiolytics 0 (0.0) 0 (0.0) 0 (0.0) 2 (1.7) 1 (0.8) 1 (0.13)

Mean (SD);

*

Several participants are on multiple medications.